# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-016097
Filing Date
2022-04-27
Accepted
2022-04-27 16:35:21
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | lyra-defa14a_20220616.htm | DEFA14A | 13712
2 | GRAPHIC | gqidinxh3iav000002.jpg | GRAPHIC | 668424
3 | GRAPHIC | gqidinxh3iav000001.jpg | GRAPHIC | 1093588
| Complete submission text file | 0001564590-22-016097.txt |  | 2441581

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39273 | Film No.: 22860285
SIC: 3841 Surgical & Medical Instruments & Apparatus